Listar por autor "González-Larriba, J. L."
Mostrando ítems 1-1 de 1
-
Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-a as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population. Castellano, D.; García del Muro, X.; Pérez-Gracia, J. L.; González-Larriba, J. L.; Abrio, M. V.; Ruiz, M. A.; Pardo, A.; Guzmán, C.; Díaz Cerezo, S.; Grande-Pulido, E. (Annals of Oncology, 2009)